The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma

Makoto Chuma,Shuhei Hige,Toshiya Kamiyama,Takashi Meguro,Atsushi Nagasaka,Kazuaki Nakanishi,Yoshiya Yamamoto,Mitsuru Nakanishi,Toshihisa Kohara,Takuya Sho,Keiko Yamamoto,Hiromasa Horimoto,Tomoe Kobayashi,Hideki Yokoo,Michiaki Matsushita,Satoru Todo,Masahiro Asaka

The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma

2009

Makoto Chuma
Shuhei Hige
Toshiya Kamiyama
Takashi Meguro
Atsushi Nagasaka
Kazuaki Nakanishi
Yoshiya Yamamoto
Mitsuru Nakanishi
Toshihisa Kohara
Takuya Sho
Keiko Yamamoto
Hiromasa Horimoto
Tomoe Kobayashi
Hideki Yokoo
Michiaki Matsushita
Satoru Todo
Masahiro Asaka

Background Prediction and prevention of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) recurrence is an important clinical issue. We investigated whether HBV DNA level and antiviral therapy are associated with HCC recurrence.

Keywords:

Hepatitis B
Viral hepatitis
Carcinoma
Hepatocellular carcinoma
Liver cancer
Cancer research
General surgery
Virology
Hepatitis B virus
Medicine
Oncology
Hepatology
Pharmacotherapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations